In addition, the supernatant cell‐free DNA (cfDNA) of the sputum is verified to be suitable for EGFR sensitive mutation detection for treatment‐naïve patients with advanced NSCLC, and especially valuable when tumor tissue is not available.11 This evidence concerns the gene EGFR and neoplasm.